
Keywords: اپشتین بار ویروس; aPLs; antiphopholipid antibodies; anti-β2GP; anti-β2 glycoprotein; APS; antiphospholipid syndrome; EBV; Epstein-Barr virus; CMV; cytomegalovirus; IM; infectious mononucleosis; VCA; viral capsid antigen; EBNA; EBV nuclear antigen; SLE; systemic lupus ery